DEVELOPMENT OF PRIMERS FOR IDENTIFICATION OF INFECTIOUS STRAINS OF STAPHYLOCOCCUS AUREUS

Авторы

  • S Abdurakhimov 1-Acad. S. Yu. Yunusov Institute of the Chemistry of Plant Substances, 2-Institute of Biophysics and biochemistry at the Mirzo Ulugbek National University of Uzbekistan
  • A Makhnyov 1-Acad. S. Yu. Yunusov Institute of the Chemistry of Plant Substances, 2-Institute of Biophysics and biochemistry at the Mirzo Ulugbek National University of Uzbekistan
  • Sh Azimova 1-Acad. S. Yu. Yunusov Institute of the Chemistry of Plant Substances, 2-Institute of Biophysics and biochemistry at the Mirzo Ulugbek National University of Uzbekistan
  • E Ibragimova 1-Acad. S. Yu. Yunusov Institute of the Chemistry of Plant Substances, 2-Institute of Biophysics and biochemistry at the Mirzo Ulugbek National University of Uzbekistan

Ключевые слова:

Staphylococcus aureus, Staphylococcus aureus PCR, antibiotics, MRSA, VRSA, primers, LB (Lysogeny broth) medium, NaCl, RSP gene, BLAST, OligoAnalyzer, UGENE, gel electrophoresis, amplicons.

Аннотация

Staphylococcus aureus is currently one of the most common pathogens of hospital-acquired surgical site infections with purulent skin and soft tissue infections of organs and abdominal cavity. Additionally, infectious strains of Staphylococcus aureus can spread rapidly in dairy products and food items. Staphylococcus aureus strains are able to produce enterotoxins A, B, C, D, E in food items, causing a food poisoning characterized by abdominal pain, vomiting, and sometimes diarrhea

Библиографические ссылки

Lambert ML, et al. 2011. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect. Dis. 11:30–38.

Iserte JA, Stephan BI, Goñi SE, Borio CS, Ghiringhelli PD, Lozano ME (2013) Family specific degenerate primer design: a tool to design consensus degenerated oligonucle otides. Biotechnol Res Int 2013:383646

Shorr AF, et al. 2006. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit. Care Med. 34: 2588–2595

MacNeal WJ, Frisbee FC. 1936. One hundred patients with Staphylococcus septicemia receiving bacteriophage service. Am. J. Med. Sci. 191: 179–189

Xu, S. X. Staphylococcal superantigens in colonization and disease / S. X. Xu, J. K. McCormick // Front Cell Infect Microbiol.—2012.—Vol. 2.—P.52.

Postępy Mikrobiologii (Advancements of Microbiology) / Jacek Bielecki—2019.—Vol. 57, No. 2.—P. 166–178.

Saiki R.K., Scharf S., Faloona F. et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia // Science. 1985. Vol. 230 (4732). P. 1350–1354.

Garafutdinov R.R., Baymiev A.Kh., Maleev G.V., Alekseev Ya.I., Zubov V.V., Chemeris D.A., Kiryanova O.Yu., Gubaydullin I.M., Matniyazov R.T., Sakhabutdinova A.R., Nikonorov Yu.M., Kuluev B.R., Baymiev A.Kh., Chemeris A.V. VARIETY OF PCR PRIMERS AND PRINCIPLES OF THEIR SELECTION // Biomics, 2019, Vol. 11, p. 23.

Mendell TH. 1939. Staphylococcus septicemia—a review of thirty-five cases, with six recoveries, twenty-nine deaths and sixteen autopsies. Arch. Intern. Med. 63:1068–1083

Wilson R, Hamburger M. 1957. Fifteen years’ experience with Staphylococcus septicemia in a large city hospital; analysis of fifty-five cases in the Cincinnati General Hospital 1940 to 1954. Am. J. Med. 22:437–457

I.S. Kovtun, M.V. Efimova// Details of selection of constitutive gene primers for polymerase chain reaction after reverse transcription// Bulletin of Tomsk State University. Biology. 2013, p. 160.

Benfield T, et al. 2007. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin. Microbiol. Infect. 13:257–263

Turnidge JD, et al. 2009. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med. J. Aust. 191:368–373

Lesens O, et al. 2003. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect. Control Hosp. Epidemiol. 24: 890–896

Asgeirsson H, Kristjansson M, Kristinsson KG, Gudlaugsson O. 2011. Staphylococcus aureus bacteraemia—nationwide assessment of treatment adequacy and outcome. J. Infect. 62:339–346

Klevens RM, et al. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763–1771

Laupland KB, Ross T, Gregson DB. 2008. Staphylococcus aureus bloodstream infections: risk factors, out comes, and the influence of methicillin resistance in Calgary, Canada, 2000–2006. J. Infect. Dis. 198:336–343

Boucher H, Miller LG, Razonable RR. 2010. Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 51 (Suppl 2): S183–S197

Kochanek KD, Xu J, Murphy SL, Minino AM, Kung H-C. 2012. Deaths: final data for 2009. National Vital Statistics Report, vol 60, no 3. National Center for Health Statistics, Hyattsville, MD. http://www.cdc.gov/nchs/data_access/vitalstatsonline.htm

Опубликован

2023-09-27

Как цитировать

Abdurakhimov, S., Makhnyov, A., Azimova, S., & Ibragimova, E. (2023). DEVELOPMENT OF PRIMERS FOR IDENTIFICATION OF INFECTIOUS STRAINS OF STAPHYLOCOCCUS AUREUS. Talqin Va Tadqiqotlar, 1(29). извлечено от https://talqinvatadqiqotlar.uz/index.php/tvt/article/view/1105